| pubmed-article:20233778 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20233778 | lifeskim:mentions | umls-concept:C0445750 | lld:lifeskim |
| pubmed-article:20233778 | lifeskim:mentions | umls-concept:C0033603 | lld:lifeskim |
| pubmed-article:20233778 | lifeskim:mentions | umls-concept:C0683598 | lld:lifeskim |
| pubmed-article:20233778 | lifeskim:mentions | umls-concept:C0449943 | lld:lifeskim |
| pubmed-article:20233778 | lifeskim:mentions | umls-concept:C1372798 | lld:lifeskim |
| pubmed-article:20233778 | lifeskim:mentions | umls-concept:C0441712 | lld:lifeskim |
| pubmed-article:20233778 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:20233778 | pubmed:dateCreated | 2010-4-9 | lld:pubmed |
| pubmed-article:20233778 | pubmed:abstractText | Protamines are cationic peptides that exert antimicrobial activity. We have examined the evolution of bacterial resistance to protamine sulphate and the resulting effects on fitness and physiology, with the objective of increasing knowledge about mechanisms of bacterial resistance to antimicrobial peptides. | lld:pubmed |
| pubmed-article:20233778 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20233778 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20233778 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20233778 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20233778 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20233778 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20233778 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20233778 | pubmed:month | May | lld:pubmed |
| pubmed-article:20233778 | pubmed:issn | 1460-2091 | lld:pubmed |
| pubmed-article:20233778 | pubmed:author | pubmed-author:AnderssonDan... | lld:pubmed |
| pubmed-article:20233778 | pubmed:author | pubmed-author:PräntingMaria... | lld:pubmed |
| pubmed-article:20233778 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20233778 | pubmed:volume | 65 | lld:pubmed |
| pubmed-article:20233778 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20233778 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20233778 | pubmed:pagination | 876-87 | lld:pubmed |
| pubmed-article:20233778 | pubmed:meshHeading | pubmed-meshheading:20233778... | lld:pubmed |
| pubmed-article:20233778 | pubmed:meshHeading | pubmed-meshheading:20233778... | lld:pubmed |
| pubmed-article:20233778 | pubmed:meshHeading | pubmed-meshheading:20233778... | lld:pubmed |
| pubmed-article:20233778 | pubmed:meshHeading | pubmed-meshheading:20233778... | lld:pubmed |
| pubmed-article:20233778 | pubmed:meshHeading | pubmed-meshheading:20233778... | lld:pubmed |
| pubmed-article:20233778 | pubmed:meshHeading | pubmed-meshheading:20233778... | lld:pubmed |
| pubmed-article:20233778 | pubmed:meshHeading | pubmed-meshheading:20233778... | lld:pubmed |
| pubmed-article:20233778 | pubmed:meshHeading | pubmed-meshheading:20233778... | lld:pubmed |
| pubmed-article:20233778 | pubmed:meshHeading | pubmed-meshheading:20233778... | lld:pubmed |
| pubmed-article:20233778 | pubmed:meshHeading | pubmed-meshheading:20233778... | lld:pubmed |
| pubmed-article:20233778 | pubmed:meshHeading | pubmed-meshheading:20233778... | lld:pubmed |
| pubmed-article:20233778 | pubmed:meshHeading | pubmed-meshheading:20233778... | lld:pubmed |
| pubmed-article:20233778 | pubmed:year | 2010 | lld:pubmed |
| pubmed-article:20233778 | pubmed:articleTitle | Mechanisms and physiological effects of protamine resistance in Salmonella enterica serovar Typhimurium LT2. | lld:pubmed |
| pubmed-article:20233778 | pubmed:affiliation | Department of Medical Biochemistry and Microbiology, Uppsala University, SE-751 23 Uppsala, Sweden. | lld:pubmed |
| pubmed-article:20233778 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20233778 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
